Abboud Hanna, MD
Nephrology · Goodyear, AZNPI 1922237072
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,578 and has fallen 73.7% since, to $677 in 2025. Among nephrology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $56.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Amgen$733
- Bayer$548
- Otsuka America Pharmaceutical, Inc.$489
- Vifor Pharma, Inc.$452
- Mallinckrodt Enterprises LLC$406
- plus $4K from 22 others
What the payments were for
- Food & beverage$8,35999%
- Education$791%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 35 | $1,886 |
| Amgen(2 entities) | 14 | $733 |
| Bayer | 8 | $548 |
| Otsuka America Pharmaceutical, Inc. | 10 | $489 |
| Vifor Pharma, Inc. | 12 | $452 |
| Mallinckrodt Enterprises LLC | 5 | $406 |
| Mallinckrodt Hospital Products Inc. | 6 | $391 |
| Portola Pharmaceuticals, LLC | 3 | $366 |
| Johnson & Johnson | 5 | $346 |
| Fresenius USA Marketing, Inc. | 3 | $335 |
| Travere Therapeutics, Inc. | 2 | $282 |
| OPKO Pharmaceuticals, LLC | 13 | $265 |
| Novo Nordisk | 2 | $229 |
| Akebia Therapeutics Inc | 6 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $191 |
| Abbott | 1 | $185 |
| GSK | 5 | $137 |
| Baxter Healthcare | 1 | $128 |
| Pfizer | 1 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $120 |
| Lilly USA, LLC | 1 | $119 |
| AbbVie | 1 | $101 |
| Nxstage Medical, Inc. | 2 | $98 |
| Actelion Pharmaceuticals US, Inc. | 1 | $97 |
| Philips North America LLC | 1 | $74 |
| Cumberland Pharmaceuticals, Inc. | 4 | $52 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Aurinia Pharma U.S., Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,438 in reported general payments places this provider in the 90th percentile of 259 nephrology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Goodyear
- Randy CooperPeoria$597K
- Minesh RajpalPeoria$403K
- Umar WaheedPeoria$150K
- Amer KhanPeoria$71K
- Samer Bani HaniPhoenix$54K
- Aneesha ShettyTucson$34K
- Leslie ThomasPhoenix$22K
- Alexander NimriPhoenix$21K
- Saeed ShaffiScottsdale$19K
- Jean RobeySun City$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.